Danish pharmaceutical leader Novo Nordisk is targeting $1 billion (Rs 8,600 crore) in sales in India with its highly successful weight-loss medication Wegovy (semaglutide) within the next five to seven years. To achieve this goal, ET has learned that
Immuno Cure BioTech, located in Hong Kong Science Park, has formed a partnership with PharmaJet to assess the safety and immunogenicity of ICVAX, Immuno Cure's HIV therapeutic DNA
The Indian Council of Medical Research’s National Institute of Immunohaematology (ICMR-NIIH) has developed the world’s first simple...
When comparing the tolerability, safety, and effectiveness of atogepant to the highest tolerated dose of topiramate in adult patients with a history of four or more migraine days per month.
Amazon India expanded its healthcare services further with the launch of Amazon Diagnostics, an in-home diagnostic testing service to deliver quick, secure, and easy lab testing to the doorsteps of customers.
Meril Life Sciences, a leading global med-tech company, marked a significant milestone with the launch of MyClip, India’s first Transcatheter Edge-To-Edge Repair (TEER) system
On June 25, 2025, the Confederation of Indian Industry (CII), Telangana will hold a day-long conference, ‘Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing’ in Hyderabad...
Building on the strong momentum of Mounjaro’s rollout in India, Eli Lilly has reported encouraging clinical trial results for its oral anti-obesity drug, Orforglipron. The new once-daily pill, part of the same GLP-1 drug class as Mounjaro and Zepboun
Following its prior report on the clinical success of Mounjaro, Eli Lilly has confirmed a considerable commercial response for the drug in India - the need for effective obesity and diabetes treatment is...
In a HIV prevention milestone, the US Food and Drug Administration (FDA) has approved Gilead Sciences' lenacapavir, a twice-a-year long-acting injection, for adults and adolescents at risk of HIV infection.
, CDSCO.jpg)
